Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

273 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Santoro A, Tursz T, Mouridsen H, Verweij J, Steward W, Somers R, Buesa J, Casali P, Spooner D, Rankin E, et al. Santoro A, et al. Among authors: rankin e. J Clin Oncol. 1995 Jul;13(7):1537-45. doi: 10.1200/JCO.1995.13.7.1537. J Clin Oncol. 1995. PMID: 7602342 Clinical Trial.
A phase II study of M-azido-pyrimethamine ethane sulphonate (MZPES) in advanced, recurrent soft tissue sarcoma. An EORTC Soft Tissue and Bone Sarcoma Group Study.
Blackledge G, Verweij J, Fuchs R, Keizer HJ, Somers R, Rankin E, Kerbrat P, van Oosterom A, Sylvester R, Thomas D, et al. Blackledge G, et al. Among authors: rankin e. Eur J Cancer Clin Oncol. 1989 Dec;25(12):1891-3. doi: 10.1016/0277-5379(89)90366-0. Eur J Cancer Clin Oncol. 1989. PMID: 2632271 No abstract available.
Mature results of a randomized trial of two doses of cisplatin for the treatment of ovarian cancer. Scottish Gynecology Cancer Trials Group.
Kaye SB, Paul J, Cassidy J, Lewis CR, Duncan ID, Gordon HK, Kitchener HC, Cruickshank DJ, Atkinson RJ, Soukop M, Rankin EM, Davis JA, Reed NS, Crawford SM, MacLean A, Parkin D, Sarkar TK, Kennedy J, Symonds RP. Kaye SB, et al. Among authors: rankin em. J Clin Oncol. 1996 Jul;14(7):2113-9. doi: 10.1200/JCO.1996.14.7.2113. J Clin Oncol. 1996. PMID: 8683244 Clinical Trial.
Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group.
Rudd RM, Gower NH, Spiro SG, Eisen TG, Harper PG, Littler JA, Hatton M, Johnson PW, Martin WM, Rankin EM, James LE, Gregory WM, Qian W, Lee SM. Rudd RM, et al. Among authors: rankin em. J Clin Oncol. 2005 Jan 1;23(1):142-53. doi: 10.1200/JCO.2005.03.037. J Clin Oncol. 2005. PMID: 15625369 Clinical Trial.
Treatment of invasive thymoma with single-agent ifosfamide.
Highley MS, Underhill CR, Parnis FX, Karapetis C, Rankin E, Dussek J, Bryant B, Rowland C, Hodson N, Hughes J, Harper PG. Highley MS, et al. Among authors: rankin e. J Clin Oncol. 1999 Sep;17(9):2737-44. doi: 10.1200/JCO.1999.17.9.2737. J Clin Oncol. 1999. PMID: 10561348
CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma.
Lundin J, Osterborg A, Brittinger G, Crowther D, Dombret H, Engert A, Epenetos A, Gisselbrecht C, Huhn D, Jaeger U, Thomas J, Marcus R, Nissen N, Poynton C, Rankin E, Stahel R, Uppenkamp M, Willemze R, Mellstedt H. Lundin J, et al. Among authors: rankin e. J Clin Oncol. 1998 Oct;16(10):3257-63. doi: 10.1200/JCO.1998.16.10.3257. J Clin Oncol. 1998. PMID: 9779699 Clinical Trial.
273 results